When APIs Break Biology: Solving Challenges in Pharma Effluent
The ETP was running. But biology was failing. A pharmaceutical manufacturer treating API-rich effluent was facing biological collapse inside their treatment system.
We didn’t treat the symptom. We traced the cause.
Analyzed effluent load and isolated DMAC-rich stream
- Deployed Advanced Oxidation Process (AOP) using H₂O₂ + UV
- Reduced DMAC load from 200 ppm to <10 ppm through pre-treatment
- Integrated treated stream into biological line
- Final polishing through RO to achieve <1 ppm at discharge
Oxidation was the turning point Once we took the API out of the equation, biology recovered naturally
DMAC levels reduced from 200 ppm to below 10 ppm after AOP
- Final treated water discharged with <1 ppm DMAC after RO polishing.
- Biological treatment stabilized no daily dosing of external bacteria cultures needed.
- Dissolved Oxygen requirement dropped by 50%, reducing blower energy consumption.
- Chemical and bio-culture costs significantly reduced.
- Operational expenditure (OPEX) cut by approximately 70%
- No major system replacement required existing ETP infrastructure retained.
Key Lessons
APIs like DMAC can break biological systems without being visibly detected in routine parameters.
- More aeration or culture dosing cannot fix toxicity-based biological failure.
- Smart segregation and targeted oxidation are more effective than symptomatic treatment.
The Challenge
- DMAC present at ~200 ppm in effluent
- Severe biological inhibition no bacterial growth
- Excessive oxygen demand (DO >4 ppm) and continuous bacterial culture dosing